223 related articles for article (PubMed ID: 20824139)
21. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
[TBL] [Abstract][Full Text] [Related]
22. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
Tamaki Y
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
[TBL] [Abstract][Full Text] [Related]
23. Neovascular age-related macular degeneration: potential therapies.
Chappelow AV; Kaiser PK
Drugs; 2008; 68(8):1029-36. PubMed ID: 18484796
[TBL] [Abstract][Full Text] [Related]
24. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
Feng L; Hu JH; Chen J; Xie X
J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
[TBL] [Abstract][Full Text] [Related]
25. Combined treatment modalities for age related macular degeneration.
Das RA; Romano A; Chiosi F; Menzione M; Rinaldi M
Curr Drug Targets; 2011 Feb; 12(2):182-9. PubMed ID: 20887244
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of neovascular age-related macular degeneration with antiangiogenic drugs].
Rodrigues EB; Rossi EE; Grumann Junior A; Meyer CH; Ho AC
Arq Bras Oftalmol; 2006; 69(5):756-65. PubMed ID: 17187150
[TBL] [Abstract][Full Text] [Related]
27. Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin4.5, induces fetal microphthalmia.
Rutland CS; Jiang K; Soff GA; Mitchell CA
Mol Vis; 2009 Jun; 15():1260-9. PubMed ID: 19572040
[TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
[TBL] [Abstract][Full Text] [Related]
29. A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.
Cano Mdel V; Karagiannis ED; Soliman M; Bakir B; Zhuang W; Popel AS; Gehlbach PL
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3840-5. PubMed ID: 19279315
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of angiogenesis in vivo by interleukin 12.
Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
[TBL] [Abstract][Full Text] [Related]
31. AMD--the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics.
Nowak JZ
Acta Pol Pharm; 2014; 71(6):900-16. PubMed ID: 25745762
[TBL] [Abstract][Full Text] [Related]
32. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
Ferrara N; Damico L; Shams N; Lowman H; Kim R
Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
[TBL] [Abstract][Full Text] [Related]
33. TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy.
Denton MD; Magee C; Melter M; Dharnidharka VR; Sayegh MH; Briscoe DM
Transplantation; 2004 Oct; 78(8):1218-21. PubMed ID: 15502723
[TBL] [Abstract][Full Text] [Related]
34. Recent Developments in the Treatment of Wet Age-related Macular Degeneration.
Papadopoulos Z
Curr Med Sci; 2020 Oct; 40(5):851-857. PubMed ID: 32980899
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of TNP-470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound.
Emoto M; Tachibana K; Iwasaki H; Kawarabayashi T
Cancer Sci; 2007 Jun; 98(6):929-35. PubMed ID: 17433035
[TBL] [Abstract][Full Text] [Related]
36. Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages.
Wang Y; Xie L; Zhu M; Guo Y; Tu Y; Zhou Y; Zeng J; Zhu L; Du S; Wang Z; Zhang Y; Liu X; Song E
Exp Eye Res; 2021 Dec; 213():108823. PubMed ID: 34752817
[TBL] [Abstract][Full Text] [Related]
37. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
Andreoli CM; Miller JW
Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Effect of
Ibuki M; Shoda C; Miwa Y; Ishida A; Tsubota K; Kurihara T
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614647
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
Song JH; Moon KY; Lee SC; Kim SS
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
Gervaz P; Scholl B; Padrun V; Gillet M
Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]